Register Here

2019 Executive Sponsors

AstraZeneca
BD Medical
Credence medsystems
Phillips-Medisize

2019 Associate Sponsors

Battelle
Flex
Halozyme
Metaphase
Owen Mumford
Pfizer
PharmaCircle
Phosphorex
Ypsomed

2019 Technology Sponsors

Adare Pharmaceuticals
Altaviz
ATS Automation
BDD Pharma
Bespak
Biocorp
Cambridge Design Partnership
CereVasc
Datwyler
DelSiTech
DSM Biomedical
Dyve Biosciences
Enable Injections
FUJIFILM Pharmaceuticals
Evonik
Gerresheimer Medical Systems
Harro Höfliger Verpackungsmaschinen GmbH
InnoCore Pharmaceuticals
leon nanodrugs
MedinCell
Nemera
Neuma
Oakwood Labs
Portal Instruments
Quantex Vernay
Sensile Medical
Serina Therapeutics
SMC Ltd
Sonceboz
Sorrel Medical
Stevanato Group
Stress Engineering

2019 Exhibitors

Baumann Group
CBSET
CSS
Drug Delivery Experts
DS Technology
Haselmeier
Ilias Biologics
Intertech
Logan Instruments
Manta
Polysciences
Product Creation Studio
Renishaw
SHL Group
Team Consulting
Ximedica

2019 Soapbox Sponsors

Curadigm
DendroPharm
DIANT Pharma
EnClear Therapies
Mitragotri Lab
Neuroparticle Corporation
Pleryon Therapeutics
Queen’s University Belfast & Technology

2019 Supporting Sponsors

Kymanox
Lyophilization Technology
TTP

2019 Media Partners

Big4Bio
Drug Development & Delivery
Gene Therapy Net
International Journal of Life science and Pharma Research – IJLPR
International Journal of Pharma and Bio Sciences -IJPBS
Med Device Online
OndrugDelivery
Pharma Tech Outlook
Pharmaceutical Online
Pharmalicensing
PHARMAnetwork
PharmaVOICE

Overview

The drug delivery industry is expected to experience robust growth over the next five to ten years, primarily due to the increasing prevalence of chronic conditions, increase in biologic drug approvals, and growing geriatric population. Often, the most complex part of developing a therapeutic is to design an appropriate delivery system for it. The use of drug delivery technologies will continue to rise, as the industry focuses on more cost-effective, targeted, and patient-centered therapies.

The 9th annual Partnership Opportunities in Drug Delivery (PODD) conference is a business development event covering the latest advances in drug delivery science, while also providing a meeting place to network and form new partnerships. The PODD event features a wide range of innovative drug delivery technologies that could potentially improve the delivery of various types of drugs, including proteins, peptides, oligonucleotides, biologics, and small molecules.

 

Key Topics for 2019

  • Nanotechnology for Immuno-oncology applications
  • Formulation & device life cycle management for biotherapeutics
  • Improving the Patient Injection Experience
  • Future Outlook for Drug Delivery
  • Device platform technologies & strategies
  • Connected health drug delivery products
  • Biologically-derived drug delivery systems
  • Technical considerations for development of patient-centered therapies
  • Delivering new therapeutic modalities

 

Harnessing the Digital Exhaust with
Dr Justin Wright
PODD Celebration

Reasons to Attend

  • Hear from renowned biomedical engineer and entrepreneur, Dr Robert Langer of MIT, as well as other leading key opinion leaders from industry and academia
  • Learn about the latest drug delivery technology solutions for both small and large molecule drugs, ranging from oral, transdermal, and transmucosal dosage forms to more patient-friendly delivery devices (more than 45 presentations and 50 exhibitors).
  • Network with key decision makers from pharmaceutical, biotechnology, and medical device companies and exploring areas for potential collaboration (more than 8 hours of networking).
  • Discover the current drug delivery needs of pharma and biotech companies and determining what they are looking for in terms of external delivery technologies.
  • Participate in discussions with colleagues tackling the latest delivery challenges in areas such as gene therapy and biologics-based new therapeutic modalities

The PODD promise:

  1. Present a strategic-level program for pharma and biotech scientists and business development professionals, with a thorough overview on formulation needs, the latest drug delivery technologies available along with an update on deals and opportunities to improve therapies and extend the life cycle of a drug.
  2. Provide drug delivery and specialty pharmas with a platform to present their technologies.
  3. Offer ample networking time and services for one-on-one meetings to establish new business contacts and enhance existing ones.

Sincerely,

Valerie Bowling New

Valerie Bowling
Executive Director

Meredith-2018

Meredith Sands
Executive Director, Business Development

Michelle McDermott
Conference Producer

Meg

Meg Gould
Senior Conference Planner

Geeta Bachani
Business Development Manager

Bre Bugbee
Marketing Manager


Testimonials

  • "Incredible! Fantastic overview of the industry, recent, partnerships and opportunities for the future. Helpful input on panels, speaker presentations and what's in the pipeline. Great networking opportunities and sharing insights with colleagues. Hard to choose just one area - was all invaluable."

    - Kristin King, Rogers Sciences

  • "Overall very satisfied. Best was networking, coming across new technologies that I did not necessarily have on the radar, and the speaker’s program."

    - Gregoire Schwach, Roche

  • "Was a great conference and getting better every year!"

    - Rudy Emmelot, IntraTab Labs

  • "I have to say PODD was a great opportunity for me. I learned a lot and met great people. Thanks to The Conference Forum."

    - Sina Eetezadi, Roche Pharmaceuticals

  • "Congratulations on a very successful conference! It is a very unique conference and I enjoyed it very much."

    - Avinash G. Thombre, PhD, Pfizer Inc

  • "I was honestly very much impressed by the conference, the set up with presentations and panels and the high level number of executives from the different stakeholders."

    - Sven Stegemann, PhD, Geriatric Medicine Society

  • "This was a great partnering event for us. In addition to our product development services, we have a couple of proprietary technologies that we are promoting. The right group of Directors, Exec Dir, VPs were at the meeting who were all looking for delivery technologies."

    - Chris Rhodes, Drug Delivery Experts